Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Characteristics of Treatment Responders to Galantamine

This study has been completed.
Janssen Korea, Ltd., Korea
Information provided by (Responsible Party):
Doh Kwan Kim, Samsung Medical Center Identifier:
First received: December 6, 2009
Last updated: January 4, 2016
Last verified: January 2016
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 2009
  Primary Completion Date: October 2009 (Final data collection date for primary outcome measure)